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Abstract 
Chlamydia species have recently been recognized as emerging pathogens in 
snakes. However, isolation of novel snake chlamydiae is critical and their growth 
characteristics are largely unknown. In this study, two novel chlamydial species are 
described: Chlamydia serpentis and Chlamydia poikilothermis, isolated after attempts 
on 23 cloacal and choanal swabs from 18 PCR-positive captive snakes originating 
from different Swiss snake collections. Isolation success, growth curve and infectivity 
rates over a 48-hour time period were dependent on temperature (37 °C for C. 
serpentis, 28 °C for C. poikilothermis). C. serpentis and C. poikilothermis were 
sensitive to tetracycline and moxifloxacin during evaluation by in vitro antibiotic 
susceptibility assay but intermediate to resistant (2–4 μg/ml) to azithromycin. Whole 
genome sequencing of the isolates provided proof of the novel species status, and 
gives insights into the evolution of these branches of genus Chlamydia. 
 
Key words: Chlamydia, snakes, Azithromycin, temperature-sensitive 
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Zusammenfassung 
Chlamydienspezies wurden als aufkommende Krankheitserreger bei Schlangen 
erkannt. Allerdings ist die Isolation von neuen Chlamydienspezies aus Schlangen 
problematisch und deren Charakterisierung ist weitestgehend unbekannt. In dieser 
Studie wurden zwei neue Chlamydienspezies beschrieben: Chlamydia serpentis und 
Chlamydia poikilothermis. Diese wurden aus 23 Choanen- und Kloakentupfer von 18 
PCR-positiven isoliert. Die Proben stammten von Schlangen in Schweizer 
Schlangenbeständen. Der Isolationserfolg, die Wachstumskurve und Infektionsrate 
über 48 Stunden waren temperaturabhängig (37 °C für C. serpentis und 28 °C für C. 
poikilothermis). Während der Evaluation der in vitro antiobiotikaempfindlichkeit waren 
C. serpentis und C. poikilothermis empfindlich gegenüber Tetrazyklin und 
Moxifloxacin aber intermediär bis resistent (2-4 μg/ml) gegenüber Azithromycin. Die 
Genomseuqenzierung der Isolate bewies den Status neuer Spezies’ und gibt einen 
Einblick in die Evolution des Genusastes der Chlamydia. 
 
Schlüsselwörter: Chlamydia, Schlangen, Azithromycin, temperaturempfindlich 
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Introduction 
Bacteria within the order Chlamydiales are biologically unique, obligate intracellular 
pathogens affecting humans, wild and domesticated mammals and reptiles, 
comprising to date nine families (reviewed in 1). Diseases and complications caused 
can include late abortions, infertility, trachoma and pneumonia. Chlamydiosis has 
been detected in both free-ranging and captive reptiles, causing granulomatous 
lesions in inner organs (2, 3, 4, 5), proliferative pneumonia (6, 7), necrotizing enteritis 
or myocarditis (8), hepatitis and conjunctivitis (9, 10) or remaining asymptomatic (7, 
11, 12). Chlamydia pneumoniae, which was initially described as a human respiratory 
pathogen, is the most commonly reported etiological agent in reptilian Chlamydiosis 
(13).  
Recent reports indicate that snakes may harbour a significant level of diverse and 
uncharacterised novel chlamydial species, in addition to Chlamydia-like organisms 
(CLOs) (5). Through near-full length chlamydial 16S rRNA gene sequencing from 21 
choanal or cloacal swab samples, C. pneumoniae strains were identified as well as 
seven novel 16S rRNA genotypes, giving the first indication of the presence of 
potentially novel Chlamydia species in snakes (11). Culture-independent full genome 
sequencing of genomic DNA obtained from the choana of a captive, clinically 
inapparent Madagascar tree boa (Sanzinia madagascariensis volontany) revealed 
the novel Candidatus species Chlamydia sanzinia (14) and similarly Candidatus 
Chlamydia corallus from the choana of a captive Amazon basin emerald tree boa 
(Corallus batesii) (15). These two new genomes show that both species fall in a 
phylogenetic clade with C. pneumoniae and C. pecorum. However, the availability of 
sample material and the lack of suited in vitro culture systems are challenges to 
further characterization of novel chlamydial strains.  
This study used in vitro culture of snake cloacal and choanal swabs with eukaryotic 
host cells at two temperatures (28°C and 37°C, considering the variable body 
temperatures of poikilothermic snake hosts) to isolate four strains belonging to two 
new chlamydial species: Chlamydia serpentis and Chlamydia poikilothermis. We 
have characterised these both phenotypically and through whole genome 
sequencing (WGS) and present the 12th and 13th species within the family 
Chlamydiaceae. 
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Results  
Detection and isolation of chlamydiae in captive snakes 
By real-time PCR, 23 swab samples from 18 individual snakes were positive for 
Chlamydiaceae. Five snakes were positive at both sites tested (choana, cloaca) 
whereas nine snakes had positive results only from the choana and the remaining 
four only from the cloaca. The Chlamydiaceae-positive snakes belonged to the 
families Boidae (n = 6), Colubridae (n = 2), Pythonidae (n = 4) and Viperidae (n = 6). 
The majority of the snakes (n = 16) were clinically asymptomatic and sampled alive, 
whereas three samples were taken from two dead snakes at necropsy. Species-
specification with the Arraymate microarray revealed the presence of C. pneumoniae 
in most samples (n = 16; 69.6%), of which one sample was also positive for C. 
muridarum. Five samples could not be further classified (21.7%), of which four were 
positive for Chlamydia sp. In addition, one sample contained C. caviae and another 
C. abortus. Details of Chlamydiaceae-positive snakes are given in Table 1. 
Isolation was attempted on swab samples (n = 13) from ten of the Chlamydiaceae-
positive snakes. Of these, isolation of Chlamydia at 28°C or 37°C was successful in 
four samples from three snakes belonging to the species Pantheropis guttatus and 
Atheris squamigera. Contamination with predominantly gram-negative, rod-shaped 
but unclassified bacteria hampered the isolation process and overgrew any 
Chlamydia in the rest of the samples. Isolation was successful at 28 °C for the strains 
named H15-1957-3C, at 37 °C for H15-1957-10C, and at both temperatures for S15-
834C and S15-834K.  
 
Phenotypic characterization of field isolates from captive snakes 
Growth experiments were performed at 28°C and 37°C with and without 
cycloheximide for the four snake isolates, using the human C. pneumoniae strain K6 
as a control. Initial growth curve experiments were performed using timepoints 24, 
32, 40 and 48 hpi (Supplementary Figure S1), but revealed very small inclusions at 
24 hpi rendering further evaluation difficult. Further experiments thus used only 32 
and 48 hpi. Infected monolayers were evaluated for titre and by IF to determine 
inclusion morphology and size, at 32 and 48 hpi (from early reticular body (RB) phase 
to mature inclusions). Regardless of timepoint and temperature, the C. pneumoniae 
strain K6, isolates H15-1957-3C and H15-1957-10C formed larger inclusions at 
earlier timepoints when cycloheximide was added (Figure 1) as compared to S15-
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834C and S15-834K (Figure 2). At 37°C, the C. pneumoniae strain K6 (Figure 1, 
panel a-d), H15-1957-3C (Figure 1, panel i-l) and H15-1957-10C (Figure 1, panel q-t) 
formed round, regular inclusions over the course of 48 hours. At 28°C, inclusions 
remained smaller at both investigated timepoints and contained mostly RB forms 
(Figure 1, panels e-h, m-p, u-x).  
In stark contrast, isolates S15-834C and S15-834K formed inclusions of 
heterogeneous appearance, mostly elongated and growing around the host cell 
nucleus in a crescent-like fashion (Figure 2). At 37°C, they regularly formed loosely 
connected, large granular RB-like structures (Figure 2, panel a-d, i-l), whereas at 28 
°C, granular inclusions consisting of EBs were seen at 48 hpi (Figure 2, panels e-h, 
m-p).  
Inclusion size was subsequently analysed at 48 hpi and compared between isolates 
and temperature (n = 50 inclusions per isolate and temperature analysed). Inclusion 
size for C. pneumoniae strain K6, H15-1957-3C and H15-1957-10C was significantly 
reduced at 28°C when compared to 37°C, with average sizes of 8.29 µm2  1.48, 
5.15 µm2  0.55 and 5.15 µm2  0.25 at 28°C, and 94.19 µm2  2.42, 94.09 µm2  
14.24 and 95.06 µm2  17.11 at 37°C (Figure 3a). The average size of inclusions 
from isolates S15-834C and S15-834K was smaller at 37°C than at 28°C though the 
difference, while significant for S15-834K (p-value = 0.0278) was not significant for 
S15-834C (p-value = 0.0718): 34.19 µm2  8.78 and 41.93 µm2  3.28 at 37°C and 
71.79 µm2  12.25 and 28.30 µm2  0.00 at 28°C (Figure 3b). 
Titration by sub-passage confirmed IF observations, showing that C. pneumoniae K6, 
H15-1957-3C and H15-1957-10C are significantly more infectious when grown at 37 
°C compared to 28 °C. The addition of cycloheximide increased the infectivity in 
these strains (Figure 4a). In contrast, the infectivity of S15-834C and S15-834K EBs 
was decreased after growth at 37 °C compared to 28 °C, and cycloheximide inhibited 
growth of these strains (Figure 4b).  
TEM of all isolates was performed at 48 hpi at 28°C and 37°C. The snake isolates 
displayed inclusions at various stages of the developmental cycle, similar in 
ultrastructure to C. pneumoniae strain K6 inclusions. In all four snake isolates, 
putative EBs are round, electron dense and, 0.25-0.5 nm in diameter. RBs are larger 
(0.5-1 mm), round to oval and more electron lucent. Binary fission of RBs and, 
occasionally, intermediate bodies (IBs, electron dense centre and more lucent 
periphery) were observed. Fully developed inclusions containing EBs, RBs and IBs 
were observed for the isolates at their respective optimum temperature, namely 37°C 
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for C. pneumoniae K6, H15-1957-3C and H15-1957-10C (Figure 5, left panel) and 
28°C for S15-834C and S15-834K (Figure 5, right panel). Interestingly, while 
inclusions at 28 °C resulted in small, RB-dominant inclusions for C. pneumoniae K6, 
H15-1957-3C and H15-1957-10C (Figure 5, right panel), S15-834C and S15-834K 
also formed 2 µm and larger sized RB-like structures, which were interpreted as 
aberrant bodies (ABs; Figure 5, left panel).  
Antibiotic susceptibility to tetracycline, moxifloxacin and azithromycin was evaluated 
for the four snake isolates. The control C. pneumoniae strain K6 was sensitive to all 
tested antimicrobial substances with MIC/MBC values ranging from 0.06 – 0.5 μg/mL 
(Table 2). All snake isolates were equally sensitive to tetracycline and moxifloxacin 
but showed an intermediate to resistant phenotype to azithromycin (Table 2).  
 
Identification of the novel snake isolates 
Initial identification using 16S rRNA genotype indicated that strains H15-1957-3C, 
H15-1957-10C are most closely related to C. pneumoniae (99% identity), whereas 
S15-834C and S15-834K are closer to C. psittaci, C. caviae and C. abortus (99% 
identity to each). Due to limitations with the resolution of 16S rRNA gene 
identification, and to gain further insights into the phylogenetic position and lifestyle of 
these bacteria, WGS was then performed on the strains used in the study, followed 
by finishing to generate complete chromosomes and manually improved automated 
annotation.  
Using an established scheme based on nine conserved taxonomically informative 
gene products (16), it was determined that the strains belong to two new species of 
the genus Chlamydia, with strains H15-1957-3C and H15-1957-10C most closely 
related to C. pneumoniae, and S15-834C and S15-834K most closely related to C. 
caviae (Figure 6). Digital DNA-DNA hybridization (dDDH) analysis comparing their 
genomes to their respective closest relative species also indicated that these isolates 
represent novel species (22.6% and 30.9% respectively; Table 3). A scheme using 
pairwise comparisons of the nine gene products used above among all Chlamydia 
species, also confirmed these as new species (16) (Supplementary Figure S2).  
These novel species were named Chlamydia serpentis (H15-1957-3C and H15-1957-
10C), and Chlamydia poikilothermis (S15-834C and S15-834K). Careful comparisons 
of the genomes showed that the C. serpentis isolates H15-1957-3C and H15-1957-
10C are identical, and the C. poikilothermis isolates S15-834C and S15-834K differ 
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only by a single base pair indel (at 32260) within an intergenic homopolymeric tract.  
 
Whole genome characteristics of novel snake species 
Features of the genomes of these novel snake species are given in Table 3, 
compared against the most closely related species, and the other sequenced species 
from a snake host, Ca. C. sanzinia (14). Both novel genomes were compared to 
representative genomes of fifteen species of the genus Chlamydia (Figure 7a and b). 
Some regions of the chromosome exhibited lower sequence conservation as 
compared to other Chlamydia genomes, including the PZ, pmp operons and tandem 
arrays of repetitive genes (Figure 7). Both the new species contain plasmids. 
The genome of C. serpentis isolate H15-1957-10C is syntenic with that of the 
comparator C. pneumoniae CWL029, but has many whole gene differences, the 
overwhelming majority of which encode hypothetical proteins, including some families 
with Chlamydia-specific domains of unknown functions (DUF) (Supplementary Table 
S1). It also possesses fewer predicted pseudogenes than the genome of CWL02 
(Table 3). 
The genome of C. poikilothermis isolate S15-834K is syntenic with that of C. caviae 
GPIC (Figure 8), showing very few whole gene differences. Most of the CDSs 
present in one strain and not the other encode hypothetical proteins (C834K_0421, 
0529, 0588, 0725-7, 0729, 0816, and 0907-8; CCA_00082, 00702, 00707) and some 
appear to reflect different numbers of tandemly arranged repetitive genes 
(C834K_0358-60, 0596-8, 0652-6, and pmp genes). In addition, the genome of C. 
poikilothermis isolate S15-834K possesses a CDS encoding a predicted alpha-
rhamnosidase (C834K_0688), bioB (C834K_00742), replaced by phage gene 
fragments in C. caviae GPIC (CCA_00721-2; 17), and a second CDS encoding a 
putative IncA homologue (C834K_0817). The CDS representing a putative non-
functional invasin (CCA_00886) is absent from the genome of C. poikilothermis 
isolate S15-834K. 
The genomes of the novel species C. serpentis and C. poikilothermis each contain 
pmp genes in four clusters in the same genomic locations (Figure 8). The genome of 
C. pneumoniae contains the highest number of pmp gene copies, but also the 
greatest number predicted to be inactivated. 
Much of the variation between strains occurs within the plasticity zone (PZ), also 
known as the replication termination region (RTR). While both the novel snake 
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species have accBC and guaAB-add gene clusters, often used to describe the ends 
of the PZ, neither carry genes encoding cytotoxins, phospholipase D, or the 
tryptophan operon. The C. serpentis genome of H15-1957-10C possesses a 2.5 kb 
putative MAC/perforin gene at Csp10C2_00153, and appears to have a PZ more 
intact than that found in the genomes of C. pneumoniae strains. In comparison, the 
C. poikilothermis genome of S15-834K has a reduced PZ relative to that within the 
genome of C. caviae GPIC. 
To rationalize the azithromycin results for the snake strains, alignments of the 23S 
rRNA gene were performed, using sequences extracted from the genomes of S15-
834K, H15-1957-10C, K6 and C. caviae GPIC. Of these, the former two possess 
intermediate resistance, and the latter two are sensitive. A single base substitution 
showing a distribution between these two groups was found, at base 1230 
(AAGGAGTA/GCTGGAGC), which does not correlate with previous findings in which 
mutations at 2058 and 2059 have been implicated in conferring azithromycin 
resistance (18, 19). 
 
Discussion 
Evidence for the existence of two additional members of the genus Chlamydia 
Analysis of four isolates originating from captive snakes of the species Pantherophis 
guttatus and Atheris squamigera has shown that the criteria for assignment of two 
new chlamydial species within the genus Chlamydia are fulfilled. First of all, 16S and 
23S rRNA sequence identity to members of the order Chlamydiales was ≥ 80%, and 
sequence identity fulfilled the assignment to the family Chlamydiaceae (16S ≥ 92.5%, 
23S ≥ 91%) according to the recent classification scheme by Pillonel et al. (16). 
Based on the comparison of nine informative marker proteins with all other 
sequenced members of the Chlamydia genus, the new isolates can be assigned to 
two new species (RpoN < 96%, FtsK < 98%, PepF < 96%, Adk < 95%, HemL < 95%) 
of the the Chlamydia genus (DnA ≥ 70%, SucA ≥ 64%, Hyp325 ≥ 57% and Fabl ≥ 
78%) (16). Whole genome average nucleotide identity (ANI) analysis of the two new 
species with their closest relatives are also lower than the 95% generally considered 
to delineate bacterial species (20) (Table 3). Previously, 16S and 23S rRNA 
sequences (21) or multilocus sequence approaches (22) were used to assign new 
chlamydial species. The scheme used in this study to classify novel snake isolates is 
based on a set of highly reliable protein sequences that were shown to be good 
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markers of whole genome relatedness (16). 
Comparative genomic analysis shows that C. serpentis, most closely related to C. 
pneumoniae, appears to have a less disrupted genome than the latter, having a more 
extensive PZ and fewer pseudogenes, perhaps therefore being more representative 
of the common ancestor of the two species. C. poikilothermis, in contrast, has a more 
reduced PZ than the closest comparator C. caviae. Comparing with the genomes of 
other known Chlamydia found in snakes (14, 15), none carry the cytotoxin or trp 
operon in the PZ, possibly implying that this improves their colonisation of snakes. 
Presence of the purine biosynthesis genes guaAB-add, however, is not required for 
growth within snakes, as this operon is absent from Ca. C. sanzinia.  
Both novel species behaved intermediate to resistant to azithromycin. According to 
Ellington et al. (23) and Tagini et al. (24), the genotypic to phenotypic congruence for 
antibiotic susceptibility may vary quite extensively from species to species and from 
antibiotics to antibiotics. Thus, the fact that these new chlamydia-related species 
exhibits a low susceptibility to azithromycin in absence of the typical mutations 
described in other species is somehow expected and highlights the limitation and 
difficulties faced when trying to infer AB susceptibility from genomic data. 
 
Description of C. serpentis sp. nov. (H15-1957-10C) 
C. serpentis (serpentis L. fem. Gen. pl. serpentum, of the snake, because snakes are 
the currently known host). 
C. serpentis strains occur in snakes belonging to the families Colubridae and 
Viperidae and were isolated from captive asymptomatic Patherophis guttatus and 
Atheris squamigera. The presence of the agent in other snake species as well as in 
free-ranging snakes and even other reptiles seems possible, but has yet to be 
investigated. C. serpentis can be recovered from choanal and cloacal swabs and 
might be also detected in inner organs of infected reptiles. The natural route of 
transmission and potential reservoirs are unknown to date. The carrier snakes were 
clinically asymptomatic, but a facultative pathogenic role has to be considered in 
concert with other bacterial or viral infections, or induced by stress due to capture 
and transportation, high-density farming and hibernation (12). The potential for 
zoonotic infection of humans, in particular snake owners, is unknown.  
C. serpentis can be grown in LLC-MK2 cells, a rhesus monkey epithelial kidney cell 
line, which has been successfully used to isolate C. suis strains from fecal swab 
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samples (25) and is able to survive and replicate at lower temperature such as 28°C 
and 12°C. The replication of C. serpentis is enhanced by adding cycloheximide after 
the infection to block de novo host protein synthesis similar as shown for C. 
pneumoniae K6. Shape, size and distribution of inclusions including their production 
of infectious EBs measured as IFU per mL at 32 and 48 hpi resemble those seen in 
C. pneumoniae-infected LLC-MK2 cells. Size of inclusions and productivity of C. 
serpentis at 28°C is diminished compared to 37°C in line with C. pneumoniae K6 in 
this study. By TEM, the typical bi-phasic developmental cycle can be observed for C. 
serpentis including EBs and RBs comparable in size and morphology to C. 
pneumoniae. C. serpentis is susceptible to tetracycline and moxifloxacin but has an 
intermediate sensitivity of azithromycin (ranging from 2 to more than 4 μg/mL). The 
type strain is H15-1957-10CT. Two strains H15-1957-10C (DSM 106151) and H15-
1957-3C (DSM 106152) have been deposited at the DSMZ (Deutsche Sammlung 
von Mikrorganismen und Zellkulturen GmbH, Braunschweig, Germany) and at CSUR 
(Collection de Souches de l’ Unité Rickettsies WDCM 875, Marseille, France). 
 
Description of C. poikilothermis sp. nov. (S15-834K) 
C. poikilothermis (poikilothermis adj., of a poikilotherm species, because this species 
was isolated from a poikilotherm reptile which is an organism whose internal 
temperature varies considerably). 
Two highly similar strains of this species occurred in a captive Pantheropis guttatus 
belonging to the family Colubridae. The agent can be recovered from choanal and 
cloacal swab and is possibly also present in other snake families, captive or free-
ranging. A pathogenic potential cannot be differentiated from the cause of death 
(salmonellosis) in the actual case. The mode of transmission and zoonotic potential 
are unknown. Like other Chlamydiaceae species, C. poikilothermis can be isolated 
and grown in cell culture but requires lower temperatures such as 28°C. Isolation at 
37°C is less successful, growth curves (Supplementary Figure S1) over time show 
the ability of C. poikilothermis to replicate at 37°C but inclusions are significantly 
smaller and morphologically similar to ABs. The replication of C. poikilothermis is not 
enhanced by adding cycloheximide. It grows better in the absence of cycloheximide 
regardless of the temperature (28°C, 37°C). By IF, the inclusion morphology at 28°C 
is heterogenous and inclusions tend to grow around host cell nuclei. The 
ultrastructural features of C. poikilothermis display EBs and RBs replicating by binary 
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fission. 
C. poikilothermis is susceptible to tetracycline and moxifloxacin but behaves 
intermediate to resistant to azithromycin (ranging from 2-4 μg/mL). The type strain is 
S15-834KT. Two strains S15-834K (DSM 106149) and S15-834C (DSM 106150) 
have been deposited at the DSMZ (Deutsche Sammlung von Mikrorganismen und 
Zellkulturen GmbH, Braunschweig, Germany) and at CSUR (Collection de Souches 
de l’ Unité Rickettsies WDCM 875, Marseille, France). 
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Material and Methods 
Snake collections, sample collection and DNA extraction 
Samples (n = 23) investigated in this study comprised choanal and cloacal swabs 
(FLOQSwabs®, Copan Italia, Brescia, Italy) taken from 18 captive snakes belonging 
to the families Boidae, Colubridae, Pythonidae and Viperidae. The majority of the 
snakes was sampled in a previous study (11) and included six private snake 
collections in Switzerland. These snakes were clinically inconspicuous at the time of 
sampling. Samples were collected as dry swabs for DNA extraction and subsequent 
chlamydial screening. Chlamydia-positive snakes were sampled again, whereas 
swabs were stored in sucrose phosphate (SP) transport medium at -80 °C for 
isolation as described (25). Additionally, two individual captive snakes, which had 
been submitted to the Institute of Veterinary Pathology (Vetsuisse Faculty, University 
of Zurich) for diagnostic purposes, were sampled during necropsy. Two swabs were 
collected per snake and anatomical location, of which one swab was stored in SP 
medium. 
 
Chlamydial screening 
DNA of dry swab samples was extracted using the QIAamp DNA mini kit (Qiagen, 
Hilde, Germany), following the supplier’s recommendations. Extracted DNA of all 
samples (n = 23) was examined using real-time PCR based on Chlamydiaceae 
family-specific 23S rRNA gene primers performed on an ABI 7500 instrument, as 
previously described (26) including internal amplification controls (27). All samples 
were tested in duplicate and the cycle threshold was set at 0.1 for each run. A mean 
cycle threshold (Ct value) < 38 was considered positive, and was used to calculate 
the corresponding chlamydial load as Chlamydiaceae 23S rRNA gene copy number 
per µl. If the amplification of internal control DNA was inhibited, the run was repeated 
following 1:10 dilution of the sample. A positive control containing a sevenfold dilution 
series of C. abortus DNA and a negative control of water instead of the template DNA 
were included in each run (28).  
All samples (n = 23) were further investigated using a species-specific 23S rRNA 
Arraymate microarray assay (Alere, Jena, Germany), as established by Borel et al. 
(29). The current version carries 34 probes for eleven Chlamydiaceae species, three 
genus-specific probes, four family markers and 15 probes for Chlamydia–like 
organisms. Additionally, there are four internal control DNA probes and an internal 
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staining control (biotin marker) (28). Each sample, including internal control DNA 
(Intype IC-DNA, Qiagen Labor, Leipzig, Germany), was amplified and biotin-labeled 
using a biotinylation PCR, as described by Borel et al. (29), with 10 minutes (min) of 
initialization (96 °C) and 40 cycles of 94 °C (denaturation), 50 °C (annealing), and 
72 °C (elongation) for 30 seconds each. 2 – 4 µl of amplification product was loaded 
on the chip, which was processed according to manufacturer’s instructions. 
 
Isolation of Chlamydia  
Isolation from swabs in SP medium was attempted on 18 swabs from 13 snakes 
positive by chlamydial screening (Table 1) as described in Wanninger et al. (25) with 
minor changes. Briefly, the isolation process was performed in LLC-MK2 cells 
(continuous Rhesus monkey kidney cell line, provided by IZSLER Brescia, Italy) 
grown on glass coverslips ( 12 mm) in 7 ml Trac bottles (Thermo Fisher Scientific, 
Waltham, MA, USA) at 37 °C and 5 % CO2. Swab samples were thawed in SP 
medium, vortexed with glass beads for 1 min and used to inoculate LLC-MK2 cells. 
Infected cells were then centrifuged for 3 hours (h) at 2385 g (28°C or 33 °C) before 
incubation for 48 to 72 h at 37 °C. If enough SP material was available, incubation 
was additionally performed at 28 °C in a second isolation attempt. Cultures were 
considered negative for viable Chlamydia if no inclusions were detected after three 
passages.  
Inclusion morphology and growth characteristics of novel snake chlamydiae 
Isolated snake chlamydial strains H15-1957-3C, H15-1957-10C, S15-834C and S15-
834K were further characterized in vitro using LLC-MK2 cells, including C. 
pneumoniae Kajaani 6 (K6) as a control (kindly provided by Dr Claudia Dumrese and 
Dr Urs Ziegler, Center for Microscopy and Image analysis, University of Zurich, 
Switzerland). LLC-MK2 cells, seeded at a density of 2.5 x 105 cells per well and 
cultivated overnight in 24-well plates in growth medium (500 ml Eagle’s minimum 
essential medium [EMEM, Gibco, Thermo Fisher Scientific, Invitrogen, Carlsbad, CA, 
USA] supplemented with 10 % heat-inactivated fetal calf serum [FCS, BioConcept, 
Allschwil, Switzerland], 5 ml L-glutamine (100X Glutamax, Gibco) and 6 ml D-(+)-
glucose [0.06 g/ml, Sigma-Aldrich Co., St. Louis, MO, USA]), were infected with 
either of the five strains at multiplicity of infection (MOI) of either 0.5 (H15-1957-3C 
and H15-1957-10C) or 1 (C. pneumoniae K6), or using an inoculum (S15-834C and 
S15-834 K) to reach an infectivity of approximately 75 % after 48 hours post infection 
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(hpi). Incubation medium, used for inoculating and incubation of cells with Chlamydia, 
consisted of EMEM supplemented with 20% FCS, 2 g glucose, 5 ml L-glutamine, 4 
ml Fungizone (250 µg/ml, Gibco) (25). Infected monolayers were centrifuged for 1 h 
at 1000 g and 25°C. After centrifugation, inocula were replaced by fresh incubation 
medium with or without 1.4 μg/ml cycloheximide (Sigma-Aldrich, St. Louis, MO, 
USA). Duplicate infected cultures were incubated at 28°C and 37°C and 5% CO2 for 
24, 32, 40 and 48 hours for preliminary evaluations. At indicated timepoints, infected 
cells were further processed for indirect immunofluorescence microscopy (IF), titre 
analysis and transmission electron microscopy (TEM). 
For IF, cells were fixed with absolute methanol (-20°C) for 10 min and chlamydial 
inclusions were visualized using a Chlamydiaceae family-specific mouse monoclonal 
antibody directed against the chlamydial lipopolysaccharide (LPS, Clone ACI-P, 
1:200; Progen, Heidelberg, Germany) and 1:500 diluted Alexa Fluor 488-conjugated 
secondary goat anti-mouse antibody (Molecular Probes, Eugene, OR, USA). Host 
and chlamydial DNA were labelled using 1 μg/ml 4’, 6-diamidino-2’-phenylindole 
dihydrochloride (DAPI, Molecular Probes). Coverslips were mounted with 
FluoreGuard mounting medium (Hard Set; ScyTek Laboratories Inc., Logan, UT, 
USA) on glass slides and evaluated using a Leica DMLB fluorescence microscope 
(Leica Microsystems, Wetzlar, Germany) under oil immersion at 1000x magnification 
with a 10x objective (PL FLUOTAR 100x/1.30, OIL, ‘/0.17/D, Leica Microsystems) 
and a 10x ocular objective (Leica L-Plan 10x/ 25 M, Leica Microsystems) as 
described (30). To determine the mean inclusion size, images were taken using a 
Leica DMLB fluorescence microscope (Leica Microsystems, Wetzlar, Germany) and 
a UI-2250SEC-HQ camera (uEye, IDS Imaging Development Systems GmbH, 
Obersulm, Germany) and analysed with the BonTec measuring and archiving 
software (BonTec, Bonn, Germany).  Depending on the inclusion size, a 
magnification of 1000x (oil immersion) or 40x was chosen and the area was 
measured with either the “Fläche(Kreis) [Area(circle)]” or “Fläche(Polygon) 
[Area(polygon)]” function depending on the shape of the inclusion. The area of at 
least 50 inclusions was measured from one or two coverslips in one or two 
independent experiments. Boxplots were created with the SPSS Statistics software. 
The QuickCalcs unpaired t test of the GraphPad software 
(https://www.graphpad.com/quickcalcs/ttest1.cfm) was used for statistical analysis.  
For titre analysis, infected monolayers were scraped into 1 ml fresh infection medium 
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at 32 and 48 hpi. Supernatant and scraped cells were pooled before storage at -
80°C. Chlamydial titration by sub-passage was evaluated to determine the infectivity 
of the isolated strains at their respective optimum temperature (C. pneumoniae K6, 
H15-1957-3C and H15-1957-10C at 37°C; S15-834C and S15-834K at 28°C) after 48 
hpi. As previously described (25), samples were vortexed for 1 min before serial 
dilution in incubation medium and subsequent infection of the prepared LLC-MK2 
cells was carried out as described for infection of host cells. Fixation and 
immunostaining was performed as described for IF. The number of inclusions in 30 
random microscopic fields for duplicate coverslips per condition was determined 
using a Leica fluorescence micro- scope at 200x magnification with a 20x objective 
(PL FLUOTAR 20x/0.50 PH 2, ‘/0.17/B) and a 10x ocular objective (Leica L-Plan 
10x/25 M, Leica Microsystems). Inclusion forming units (IFU) per ml of undiluted 
inoculum was then calculated. 
For TEM analysis, cells were fixed with 2.5% glutaraldehyde (Electron Microscopy 
Sciences, Ft. Washington, USA) for 1 h and embedded in epoxy resin (Fluka; Sigma-
Aldrich).  
 
Antibiotic susceptibility testing  
Antibiotic susceptibility testing of the four snake isolates (H15-1957-3C, H15-1957-
10C, S15-834C and S15-834K) and the human C. pneumoniae isolate K6 was 
performed as described previously (25, 31). Antimicrobial drugs included tetracycline 
(Sigma-Aldrich), moxifloxacin (Sigma-Aldrich) and azithromycin (Sigma-Aldrich).  
Briefly, we collected chlamydiae-positive cultures in SP media and determined the 
number of inclusion forming units per ml (IFU/ml) via 10-fold dilution as described 
(25, 31) Each antibiotic susceptibility determination was performed with 
approximately 5 x 103 IFU/mL per investigated isolate (31, 32). Following inoculation 
of sixteen confluent monolayers and centrifugation (1 h, 2385 g, 33 °C), inocula were 
replaced with incubation medium containing a serial two-fold dilution of the 
antimicrobial agent in question. After a 48-hour incubation period at their optimum 
temperature (28 °C or 37 °C), monolayers were fixed in methanol for 10 min, 
immunolabelled and processed with a fluorescein-conjugated monoclonal antibody 
specific for the chlamydial LPS genus-specific antigen (IMAGEN Chlamydia 
K610111-2, Thermo Fisher Scientific) as described (25). 
The minimum inhibitory concentration (MIC) of the respective antibiotic substance 
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was defined as “the lowest concentration preventing the detection of more than 90% 
of the chlamydial inclusions compared with the drug-free control” (31, 32). In parallel, 
media of the remaining Trac bottles was replaced with antibiotic-free chlamydiae 
cultivation medium after washing the coverslips with PBS. Monolayers were fixed 
after 48 h of incubation and immunolabelled for the evaluation of the minimum 
bactericidal concentration (MBC), which was identical to MIC determination. 
Chlamydial isolates with an MIC/MBC of 4 μg/mL were defined as resistant, whereas 
cultures with 2 μg/mL  MIC/MBC < 4 μg/mL were considered intermediate, and 
isolates with a MIC/MBC of < 2 μg/mL sensitive.  
 
Identification using 16S rRNA gene analysis 
Initial genotyping was performed by sequencing the 16S rRNA gene using the 
Chlamydiales-specific primer pair 16SIGF (5’- CGGCGTGGATGAGGCAT-3’) and 
16SB1 (5’-TACGGYTACCTTGTTACGACTT-3’) (33) targeting almost the entire gene 
(approximately 1400 bp) as described (11). PCR products were purified with the 
QIAquick PCR Purification Kit (Qiagen) according to manufacturer’s instructions. 
Purified DNA was Sanger sequenced by Microsynth (Balgach, Switzerland).  
 
WGS, mapping, assembly and annotation  
Sequencing of the four snake isolates (H15-1957-3C, H15-1957-10C, S15-834C and 
S15-834K) and the human C. pneumoniae isolate K6 was performed on the Illumina 
Miseq platform with 250 bp paired end reads at the Functional Genomics Center 
Zurich (FGCZ), following NEBNext library creation. Coverage data is shown in 
Supplementary Table S2. Assembly was performed using SPAdes in multi-cell mode 
(34), followed by ordering of the chlamydial contigs against C. pneumoniae CWL029 
(accession number AE001363) or C. psittaci 01DC12 (HF545614) within ACT (35). 
The contig order was confirmed, and genomes finished, by amplifying and capillary 
sequencing across gaps using the primers listed in Supplementary Table S3. The 
resulting single contig genome assemblies were checked and compared using BWA 
(36). The genome of K6 remained in two contigs. Automated annotation was 
performed using AnnotateBacteria [https://github.com/sanger-pathogens/Bio-
AutomatedAnnotation/] with further manual curation in Artemis (35, 37). All read data, 
with associated assembly and annotation where relevant, has been submitted to ENA 
under project PRJEB19768. 
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Phylogenetic and genome analysis 
Average nucleotide identity (ANI) determination was performed at enve-
omics.ce.gatech.edu/ani/ (20) and digital DNA-DNA hybridisation (dDDH) using 
GGDC2.1 (ggdc.dsmz.de/distalcalc2.php) and the DDH cut off of ≤70% (38). 
Comparator genomes used were C. pneumoniae CWL029 (accession number 
AE001363) (39) and C. caviae GPIC (AE015925) (17). Comparisons were performed 
using tblastx, visualized in ACT, to identify novel and duplicated genes. 
Nine phylogenetically informative markers were identified with hmmsearch v3.1 
(http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1002195) using 
hmm profiles built from 21 reference sequences (16). Amino acid sequences were 
aligned with mafft (parameters: --auto --maxiterate 1000). Alignments were 
concatenated to build a reference phylogeny using Phyml v 3.1 
(https://www.ncbi.nlm.nih.gov/pubmed/20525638), with the LG+Г+I model and 100 
bootstrap replicates. Pairwise amino acid sequence identities were calculated based 
on pairwise Needleman-Wunsch global alignments (EMBOSS:6.6, 
https://www.ncbi.nlm.nih.gov/pubmed/10827456). Amino acid sequences of predicted 
coding sequences were clustered into orthologous groups with Orthofinder v. 0.4 
(https://genomebiology.biomedcentral.com/articles/10.1186/s13059-015-0721-2). 
 
 
 
 
  
 19 
References 
 
1. Taylor-Brown, A., Vaughan, L., Greub, G., Timms, P. & Polkinghorne, A. Twenty years of 
research into Chlamydia-like organisms: a revolution in our understanding of the biology and 
pathogenicity of members of the phylum Chlamydiae. Pathog. Dis. 73, 1-15 (2015). 
 
2. Jacobson, E.R., Gaskin, J.M. &Mansell, J. Chlamydial infection in puff adders, Bitis 
arietans. J. Zoo. Wildl. Med. 20, 364-369 (1989). 
 
3. Jacobson, E.R. & Telford, S.R. Chlamydia and poxvirus infection of monocytes in a flap-
necked chameleon. J. Wild. Dis. 26, 572-577 (1990). 
 
4. Jacobson, E., Origgi, F., Heard, D. & Detrisac, C. Immunohistochemical staining of 
chlamydial antigen in emerald tree boas (Corallus caninus). J. Vet. Diagn. Investig. 14, 487–
494 (2002).  
 
5. Soldati, G. et al. Detection of mycobacteria and chlamydiae in granulomatous 
inflammation of reptiles: a retrospective study. Vet. Pathol. 41, 388–397 (2004).  
 
6. Jacobson, E.R., Heard, D. & Andersen, A. Identification of Chlamydophila pneumoniae in 
an emerald tree boa, Corallus caninus. J. Vet. Diagn. Investig. 16, 153–154 (2004).  
 
7. Frutos, M.C., Monetti, M.S, Re, V.E. & Cuffini, C.G. Molecular evidence of 
Chlamydophila pneumoniae infection in reptiles in Argentina. Rev. Argent. Microbiol. 46, 
45–48 (2014).  
 
8. Homer, B.L., Jacobson, E.R., Schumacher, J. & Scherba, G. Chlamydiosis in mariculture-
reared green sea turtles (Chelonia mydas). Vet. Pathol. 31, 1-7 (1994). 
 
9. Huchzermeyer, F.W., Gerdes, G.H., Foggin, C.M., Huchzermeyer, K.D. & Limper L.C. 
Hepatitis in farmed hatchling Nile crocodiles (Crocodylus niloticus) due to chlamydial 
infection. J. S. Afr. Vet. Assoc. 65, 20-22 (1994). 
 
10. Huchzermeyer, F.W., Langelet, E. & Putterill, J.F. An outbreak of chlamydiosis in farmed 
Indopacific crocodiles (Crocodylus porosus). J. S. Afr. Vet. Assoc. 79, 99-100 (2008). 
 20 
 
11. Taylor-Brown, A., Rüegg, S., Polkinghorne, A. & Borel, N. Characterisation of 
Chlamydia pneumoniae and other novel chlamydial infections in captive snakes. Vet. 
Microbiol. 178, 88-93 (2015). 
 
12. Rüegg, S.R., Regenscheit, N., Origgi, F.C., Kaiser, C. & Borel N. Detection of Chlamydia 
pneumoniae in a collection of captive snakes and response ot treatment with marbofloxacin. 
Vet. J. 205, 424-426 (2015). 
 
13. Bodetti, T.J. et al. Molecular evidence to support the expansion of the hostrange of 
Chlamydophila pneumoniae to include reptiles as well as humans, horses, koalas and amphi- 
bians. Syst. Appl. Microbiol. 25, 146–152 (2002).  
 
14. Taylor-Brown, A., Bachmann, N.L., Borel, N. & Polkinghorne, A. Culture-independent 
genomic characteriation of Candidatus Chlamydia sanzinia, a novel uncultivated bacterium 
infecting snakes. BMC Genomics. 17, 710 (2016). 
 
15. Taylor-Brown, A., Spang, L., Borel, N. & Polkinghorne, A. Culture-independent 
metagenomics supports discovery of uncultivable bacteria within the genus Chlamydia. Sci 
Rep. 7(1), 10661 (2017). 
 
16. Pillonel, T., Bertelli, C., Salamin, N. & Greub, G. Taxogenomics of the order 
Chlamydiales. Int. J. Syst. Evol. Microbiol. 65, 1381-93 (2015). 
 
17. Read, T.D. et al. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): 
examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic 
Acids Res. 31, 2134-2147 (2003). 
 
18. Binet, R., Bowlin, A.K., Maurelli, A.T. & Rank, R.G. Impact of azithromycin resistance 
mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. Antimicrob. 
Agents. Chemother. 54, 1094-101 (2010). 
 
19. De Barsy, M., Bottinelli, L. & Greub, G. Antibiotic susceptibility of Estrella 
lausannensis, a potential emerging pathogen. Microb. Infect. 16, 746-754 (2014). 
 
 21 
20. Goris, J. et al. DNA-DNA hybridization values and their relationship to whole-genome 
sequence similarities. Int. J. Syst. Evol. Microbiol. 57, 81-91 (2007). 
 
21. Everett, K.D., Bush, R.M. & Andersen, A.A. Emended description of the order 
Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each 
containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a 
new genus and five new species, and standards for the identification of organisms. Int. J. Syst. 
Bacteriol. 49, 415–440 (1999). 
 
22. Pannekoek, Y. et al. Multi locus sequence typing of Chlamydiales: clonal groupings 
within the obligate intracellular bacteria Chlamydia trachomatis. BMC. Microbiol. 8, 42 
(2008). 
 
23. Ellington, M.J. et al. The role of whole genome sequencing in antimicrobial susceptibility 
testing of bacteria: report from the EUCAST Subcommittee. Clin Microbiol Infect. 23(1), 2-
22 (2017). 
 
24. Tagini, F. et al. Importance of whole genome sequencing for the assessment of outbreaks 
in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes 
infections. Eur J Clin Microbiol Infect Dis. 36(7), 1173-1180 (2017). 
 
25. Wanninger, S. et al. Selective pressure promotes tetracycline resistance of Chlamydia suis 
in fattening pigs. PLos. One. 11, e0166917 (2016).  
 
26. Ehricht, R., Slickers, P., Goellner, S., Hotzel, H. & Sachse, K. Optimized DNA 
microarray assay allows detection and genotyping of single PCR-amplifiable target copies. 
Mol. Cell. Probes. 20, 60-63 (2006). 
 
27. Blumer, S., et al. Waddlia, Parachlamydia and Chlamydiaceae in bovine abortion. Vet. 
Microbiol. 152, 385-93 (2011). 
 
28. Hoffmann, K., et al. Prevalence of chlamydial infections in fattening pigs and their 
influencing factors. PLos. One. 10, e0143576. doi: 10.1371/journal.pone.0143576 (2015). 
 
29. Borel, N., et al. Direct identification of chlamydiae from clinical samples using a DNA 
 22 
microarray assay: a validation study. Mol. Cell. Probes. 22, 55-64 (2008). 
 
30. Leonard, C.A., Schoborg, R.V. & Borel, N. Damage/Danger associated molecular patterns 
(DAMPs) modulate Chlamydia pecorum and C. trachomatis serovar E inclusion development 
in vitro. PLoS. One. 10, e0134943 (2015). 
 
31. Donati, M., et al. Comparative in-vitro activity of moxifloxacin, minocycline and 
azithromycin against Chlamydia spp. J. Antimicrob. Chemother. 43, 825-827 (1999). 
 
32. Donati, M., et al. In vitro activities of several antimicrobial agents against recently 
isolated and genotyped Chlamydia trachomatis urogenital ser- ovars D through K. J. 
Antimicrob. Chemother. 54, 5379–80 (2010).  
 
33. Hosokawa, T., Kikuchi, Y., Nikoh, N., Shimada, M. & Fukatsu, T. Strict host-symbiont 
cospeciation and reductive genome evolution in insect gut bacteria. PLoS. Biol. 4, e337 
(2006).  
 
34. Bankevich, A., et al. SPAdes: a new genome assembly algorithm and its applications to 
single-cell sequencing. J. Comput. Biol. 19, 455-477 (2012).  
 
35. Carver, T.J., et al. ACT: the Artemis Comparison Tool. Bioinformatics. 21, 3422-3423. 
doi: 10.1093/bioinformatics/bti553 (2005). 
 
36. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler 
Transform. Bioinformatics. 25, 1754-1760 (2009).  
 
37. Rutherford, K.M. et al. Artemis: sequence visualization and annotation. Bioinformatics. 
16, 944-945 (2000).  
 
38. Auch A, Von Jan M, Klenk H-P, Göker M. Digital DNA-DNA hybridization for microbial 
species delineation by means of genome-to-genome sequence comparison. Stand. Genomic. 
Sci. 2, 117-134. doi: 10.4056/sigs.531120 (2010). 
 
39. Kalman, S., et al. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. 
Nat. Genet. 21, 385-389 (1999).
Acknowledgements 
The authors are grateful to Sabrina Wanninger, Institute of Veterinary Pathology, 
Vetsuisse Faculty, University of Zurich, and the Functional Genomics Centre Zurich, 
in particular Dr Lucy Poveda, for excellent technical assistance. We thank Dr Simon 
Rüegg, Section of Veterinary Epidemiology, Vetsuisse Faculty, University of Zurich, 
for sample collection. The collection and molecular analysis of the snake samples 
was approved and performed in accordance with the relevant guidelines and 
regulations of the Veterinary Office of canton Zurich (authorization no. ZH010/15). 
This work was partially supported by the Swiss Association for Wildlife, Zoo and 
Exotic Animals to NB.  
 
Author contributions statement 
Designed the study: N.B., M.D., C.A.L. and H.M.B.S. 
Collected the samples: E.S. and S.L. 
Performed the experiments: E.S., H.M., R.B., A.L., C.A.L. and S.L. 
Analyzed the data: E.S., H.M., R.B., A.L., C.A.L., T.P., H.M.B.S., G.G. and N.B. 
Prepared the manuscript and figures: H.M., T.P., H.M.B.S. and N.B. 
Reviewed and approved the manuscript: all authors. 
 
Competing financial interests 
No conflict of interest declared. 
 
 
Curriculum Vitae 
 
Vorname Name Eveline Staub 
Geburtsdatum 24. Juni 1992 
Geburtsort Meilen ZH 
Nationalität Schweiz 
Heimatort Altstätten SG 
 
August 1998 – Juli 2004 
August 2004 – Juli 2006 
August 2006 – Juni 2010 
Schulausbildung (Schulbezeichnung, Ort, Land) 
Primarschule St.Gallenkappel 
Sekundarschule Eschenbach 
Kantonsschule Wattwil 
 
25. Juni 2010 
Höchster Schulabschluss 
Matura 
  
 
September 2010 – 
August 2017 
Studium (Fachgebiet, Universität, Ort, Land) 
Veterinärmedizinstudium Universität Zürich 
 
30. September 2017 
Abschlussprüfung vet. med. Universität Zürich, Zürich, 
Schweiz 
 
  
Mai 2017 – April 2018 Anfertigung der Dissertation  
 –  unter Leitung von Nicole Borel 
 am Institut für Veterinärpathologie der Vetsuisse-Fakultät 
Universität Zürich, Direktor: Anja Kipar 
  
 Alle fachrelevanten Anstellungen nach Abschluss des 
veterinärmedizinischen Studiums bis zum Einreichen der 
Dissertation in chronologischer Reihenfolge 
  
Januar 
2018 
– Bis auf 
weiteres 
Assistentin Tierärztepraxis Pool, Uznach, Schweiz 
 
 
 
  
 Figure legends 
Figure 1. Immunofluorescence images of C. pneumoniae K6, H15-1957-3C and 
H15-1957-10C at 32 and 48 hours post infection (hpi). Shown are representative 
immunofluorescence images illustrating the morphology of C. pneumoniae K6 (a-h), 
H15-1957-3C (i-p), H15-1957-10C (q-x) at 32 hpi (columns 1 & 3) and 48 hpi 
(columns 2 & 4) in the presence (columns 1-2) or absence (columns 3-4) of 
cycloheximide. Strains were grown at 37 °C (top line per strain; lines 1, 3, 5) and 28 
°C (bottom lane per strain; lines 2, 4, 6). The size bar indicates 5 µm. Chlamydial 
inclusions are shown in green, the LLC-MK2 nuclei (DAPI) are shown in blue. 
 
Figure 2. Immunofluorescence images of S15-834C and S15-834K at 32 and 48 
hours post infection (hpi). Shown are immunofluorescence images illustrating the 
morphology of S15-834C (a-h) and S15-834K (i-p) at 32 hpi (columns 1 & 3) and 48 
hpi (columns 2 & 4) in the presence (columns 1-2) or absence (columns 3-4) of 
cycloheximide. Strains were grown at 37 °C (top line per strain; lines 1, 3,) and 28 °C 
(bottom lane per strain; lines 2, 4,). The size bar indicates 5 µm. Chlamydial 
inclusions are shown in green, the LLC-MK2 nuclei (DAPI) are shown in blue. 
 
Figure 3. The average inclusion size of C. pneumoniae K6, H15-1957-3C and 
H15-1957-10C is significantly decreased following incubation at 28 °C 
compared to 37 °C. Shown is a boxplot comparing the inclusion size (µm2) 
distribution for strains a) C. pneumoniae K6, H15-1957-3C and H15-1957-10C, and 
b) S15-834C and S15-834K following 48 h of incubation at 28 °C (dark grey) or 37 °C 
(light grey). Filled circles represent outliers (>1.5x interquartile range), while asterisks 
represent extreme values (>3x interquartile range). The inclusion size was 
determined using a Leica DMLB fluorescence microscope (Leica Microsystems, 
Wetzlar, Germany) and a UI-2250SEC-HQ camera (uEye, IDS Imaging Development 
Systems GmbH, Obersulm, Germany) and analysed with the BonTec measuring and 
archiving software (BonTec, Bonn, Germany). Boxplots were created by the SPSS 
Statistics software. An unpaired t test was used for statistical analysis, and a p-value 
of less than 0.05 was considered significant. 
 
Figure 4. Titration by sub-passage confirmed that the infectivity of C. 
pneumoniae K6, H15-1957-3C and H15-1957-10C is significantly higher at 37 °C 
while the infectivity of strains S15-834C and S15-834K is increased at 28 °C. 
 LLC-MK2 cells were infected with one chlamydial strain of a) either C. pneumoniae 
K6, H15-1957-3C, H15-1957-10C, or b) S15-834C, S15-834K and incubated for 48 
hours at 28 °C or 37 °C in the presence (white bars) or absence (black bars) of 
cycloheximide. At 48 hours post infection, monolayers were scraped into the 
supernatant and used for titration by sub-passage. Inclusion forming units (IFU/ml) 
are shown in a logarithmic scale. Asterisks indicate statistical significance (p < 0.05) 
by unpaired t test. 
 
Figure 5. The ultrastructure of C. pneumoniae K6, H15-1957-3C and H15-1957-
10C is similar with fully developed inclusions at 37 °C as opposed to 28 °C, 
while strains S15-834C and S15-834K form mature inclusions at 28 °C and 
show indication for the presence of aberrant bodies (ABs) at 37 °C. Cultures 
were fixed in glutaraldehyde at 48 hours post infection and processed for 
transmission electron microscopy. Shown is the ultrastructure of C. pneumoniae K6, 
H15-1957-3C, H15-1957-10C, S15-834C and S15-834K (top to bottom) following 
incubation at 37 °C (left column) or 28 °C (right column). The size bar indicates 10 
µm. N = nucleus, Nc = nucleolus, Chlc = chlamydial inclusion, Cy = cytoplasm, 
I =intercellular space. 
 
Figure 6. Phylogeny of the genus Chlamydia including the new species. The 
phylogeny was reconstructed based on the concatenated alignment of 9 
phylogenetically informative protein markers (16), and includes one representative of 
each species whenever genomic data is available. Bootstrap values are shown as 
percentages. The scale bar indicates the number of amino acid substitutions per site. 
 
Figure 7. Circular representation of the chromosomes illustrating protein 
sequence conservation compared with other representatives of the 
Chlamydiaceae. The predicted CDSs are shown on the outer circle in forward or 
reverse frames. rRNA genes are shown in blue. The inner circles represent identities 
of the closest orthologue of each CDS identified using Orthofinder, compared against 
reference genomes. The genomes are ordered based on average sequence identity 
(see key) as below. Regions showing lower conservation are indicated. A) C. 
serpentis H15-1957-10C: C. pneumoniae CWL029, C. poikilothermis. 834K, C. 
psittaci 6BC, C. felis Fe/C-56, C. caviae GPIC, Ca. C. sanzinia 2742-308, C. abortus 
S26/3, C. pecorum E58, C. gallinacea 08-1274/3, Ca. C. ibidis 10-1398/6, C. 
 muridarum Nigg, C. trachomatis D/UW-3/CX, C. avium 10DC88, C. suis MD56, 
Waddlia chondrophila WSU 86-1044. B) C. poikilothermis S15-834K: C. psittaci 6BC, 
C. caviae GPIC, C. felis Fe/C-56, C. abortus S26/3, C. serpentis 10C, C. pneumoniae 
CWL029, Ca. C. sanzinia 2742-308, C. gallinacea 08-1274/3, Ca. C. ibidis 10-
1398/6, C. pecorum E58, C. muridarum Nigg, C. trachomatis D/UW-3/CX, C. avium 
10DC88, C. suis MD56, Waddlia chondrophila WSU 86-1044. The two inner plots 
indicates the G+C content (blue for above average and red for below average) and 
G+C skew (blue for positive and green for negative). 
 
Figure 8. Comparison of the genomes of (top to bottom) C. pneumoniae 
CWL029, C. serpentis H15-1957-10C, C. poikilothermis S15-834K and C. caviae 
GPIC. Each horizontal line represents the genome, with CDSs shown directionally as 
arrow heads. Identity (tblastx) between the genomes is shown according to the scale 
bar. Pink CDSs represent pmp genes, and brown disrupted pmp genes. The 
genomes of S15-834K and C. caviae GPIC have been reverse complemented to 
illustrate the synteny. The plasticity zone (PZ) locus is indicated. 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
 Table 1 1 
Details of snakes positive by real-time PCR for Chlamydiaceae. Samples were collected from asymptomatic alive snakes or taken at 2 
necropsy from dead snakes. 3 
Collection
ID 
Snak
e no. 
Sample 
no.1  / 
Strain ID 
Snake species 
Live (L) 
Necropsy 
(N) 
Real-time 
PCR (  Ct 
value) 
Real-time PCR 
(  quantity, 
copies/µl) 
Arraymate 
Isolatio
n 
A 
1 
H15-1957-
3C 
Pantherophis 
guttatus 
L 24.9 42’511 
C. 
pneumoniae 
Yes 
2 
H15-1957-
10C 
H15-1957-
10K 
Atheris 
squamigera 
L 
32.5 
33.4 
330 
188 
C. 
pneumoniae 
C. 
pneumoniae 
Yes 
No 
B 
3 
H15-1971-
20C 
H15-1971-
20K 
Sanzinia 
madagascariensis 
voluntar 
L 
26.0 
30.4 
21’767 
1’280 
Chlamydia4 
Chlamydia4 
No 
Not 
done 
4 
H15-1971-
22C 
H15-1971-
22K 
Python regius L 
29.32 
29.7 
3’4102 
2’105 
C. 
pneumoniae 
C. 
pneumoniae 
No 
No 
C 
5 
H15-2055-
65K 
Python m. molurus L 18.4/UT3 2’354’763/UT3 
C. 
pneumoniae 
Not 
done 
6 H15-2055- Crotalus basilicus L 29.5 3’182 C. Not 
 69C pneumoniae done 
7 
H15-2055-
70C 
Crotalus basilicus L 26.9 15’388 
C. 
pneumoniae 
Not 
done 
8 
H15-2055-
71C 
Crotalus basilicus L 25.4 36’997 
C. 
pneumoniae4 
Not 
done 
9 
H15-2055-
72C 
Crotalus basilicus L 29.2 4’206 
C. 
pneumoniae 
C. muridarum 
Not 
done 
10 
H15-2055-
79C 
H15-2055-
79K 
Python regius L 
33.7 
26.2 
190 
26’165 
C. 
pneumoniae4 
C. 
pneumoniae 
Not 
done 
Not 
done 
D 11 
H15-2833-
20C 
Python regius L 29.5 2’547 
C. 
pneumoniae4 
Not 
done 
E 
 
 
12 
H15-2898-
1C 
Eunectes murinus L 30.9 932 Chlamydia4 No 
13 
H15-2898-
2C 
Eunectes murinus L 26.5 16’134 
C. 
pneumoniae4 
No 
14 
H15-2898-
3K 
Eunectes murinus L 14.1 212’659’086 Negative5 No 
15 
H15-2898-
13C 
Eunectes murinus L 29.6 9’245 Chlamydia 4 No 
 F 16 
H15-2641-
14K 
Boa constrictor L 26.8 17’286 C. abortus No 
G 17 S15-212-K Crotalus cerastes N 24.8 35’424 
C. 
pneumoniae4 
Not 
done 
H 18 
S15-834C 
S15-834K 
Pantherophis 
guttatus 
N 
25.0 
18.2 
14’272 
4’372’828 
C. caviae 
C. 
pneumoniae 
Yes 
Yes 
1C = swab samples from choana; K = swab sample from cloaca 4 
2Samples diluted 1:10 for analysis 5 
3UT = undetermined 6 
4Suspected genus/species based on Arraymate probes 7 
5possible false-positive real-time PCR result 8 
 Table 2 9 
Antibiotic susceptibility testing results of the four snake isolates and the human C. pneumoniae strain K6. Chlamydial isolates with a 10 
MIC/MBC of 4 μg/mL were defined as resistant, whereas cultures with 2 μg/mL  MIC/MBC < 4 μg/mL were considered intermediate and 11 
isolates with a MIC/MBC of < 2 μg/mL were sensitive. 12 
 13 
Isolate Tetracycline (μg/mL) Moxiflocaxin (μg/mL) Azithromycin (μg/mL) 
MIC MBC MIC MBC MIC MBC 
C. 
pneumoniae 
K6 
0.125-0.25 0.25-0.5 0.06-0.125 0.06-0.125 0.25 0.25 
H15-1957-3C 0.5-1 1-2 0.5-1 1 2 4 
H15-1957-10C 0.25-0.5 0.5  0.06 0.06  4  4 
S15-834C 0.25 1  0.06 0.06 2-4  4 
S15-823K 0.25 1  0.06 0.06 2-4  4 
 14 
 15 
  Table 3 16 
Properties of genomes of novel species compared to these of close relatives and one other species isolated from a snake host. T3SS: 17 
type III 18 
secretion system, PLD: Phospholipase D. 19 
 20 
Species C. pneumoniae C. serpentis C. caviae C. poikilothermis Ca. C. sanzinia 
Host Human Snake Guinea pigs Snake Snake 
Disease pneumonia / 
bronchitis 
undetermined genital / ocular undetermined undetermined 
Strain CWL029 H15-1957-10C GPIC S15-834K 2742-308 
Accession 
number(s) 
AE001363 ERZ462351-2 AE015925-6 ERZ462353-4 CP014639 
Publication Kalman NG 1999 
(41) 
This publication Read NAR 2003 (17) This publication Taylor-Brown BMCG 
2016 (14) 
Genome size 1230230 1198609 1173390 1155104 1113073 
Predicted CDSs 1073 985 1009 979 998 
Plasmid N (only in strain 
N16) 
7533bp 7966bp 7559bp 7504bp 
        
dDDH 22.60% 30.90%   
Novel species 
probability 
98.50% 100%   
 ANI genome 80.82% 86.01%   
        
Virulence 
associated 
      
ompA Cpn_0695 C10C_0661 CCA_00047 C834K_0054 Cs308_0329 / 0497 
T3SS Y Y Y Y Y 
tarp Cpn_0572 C10C_0530 CCA_00170 C834K_0183 Cs308_0200 
tarp repeats N Y N N Y 
pmp genes 22 (6 
pseudogenes) 
18 18 (1 pseudogene) 19 (3 pseudogenes) 19 (2 pseudogenes) 
Locus_tags Cpn_0005, 0013, 
0444-7, 0451, 
0453-4, 0466-7, 
0471, 0539-40, 
0963 
C10C_0005,0007-8, 
0410-4, 0416, 0419-20, 
0424-7, 0495-6, 0936 
CCA_00205-6, 
00271-5, 00277-84, 
00624, 00806 
C834K_0221-2, 
0291-7, 0299, 0302-
5, 0642, 0828 
Cs308_0065, 0068, 
0078, 0080, 0163-4, 
0586 
pmp clusters 4 4 4 4 4 
bioABD Cpn_1041-4 C10C_1013-8 N  - replaced by 
phage fragment 
C834K_0742 (bioB) Cs308_0663-6 
udk / upp Cpn_0735 (udk) C10C_0705 (udk) N N N 
incA, B, C Cpn_0186, 0585, 
0291-2 
C10C_0160, 0545, 
0261-2 
CCA_00550, 00491-0 C834K_0578, 0817, 
0516-5 
Cs308_0059, 0863-4 
  Two incA Two incA homologues  Two incA   
 homologues homologues 
        
PZ / RTR       
accBC Cpn_0182-3 C10C_0156-7 CCA_00553-4 C834K_0581-2 Cs308_0799-800 
guaAB-add Cpn_0170-2 
(pseudogenes) 
Cs0C_0149-52 CCA_00572-4 C834K_0590-2 N 
cytotoxin N N CCA_00558 N N 
PLD N N N N N 
MAC/perforin Cpn_0176 C10C_0153 CCA_00560 
(pseudogene) 
N N 
trp operon N N CCA_00562-7 N N 
        
Pseudogenes 
(curated) 
Cpn_0014-5 (pmp) C10C_0926 (ispE) CCA_00285 (pmpG) C834K_0289 (pmp) Cs308_0073 (pmp) 
  Cpn_0016-7 (pmp)  CCA_00288 (gatA) C834K_0300 (pmp) Cs308_0075 (pmp) 
  Cpn_0018-9 (pmp)  CCA_00326 
(hypothetical) 
C834K_0310 (pmp)   
  Cpn_0170 (add)  CCA_00515 
(hypothetical) 
C834K_0638 
(hypothetical) 
  
  Cpn_0171 (guaA)  CCA_00560 
(MAC/perforin) 
C834K_0657 (cons. 
hypothet) 
  
  Cpn_0267-8 (incA)  CCA_00886 (invasin)    
   Cpn_0339-41 
(recF) 
     
  Cpn_0449-50 
(pmp) 
     
  Cpn_0452 (pmp)      
  Cpn_0470 (pmp)      
  Cpn_0954-5 (ispE)      
  
